Evaluation and comparison of the antimicrobial efficacy of teicoplanin- And clindamycin-coated titanium implants: An experimental study

Journal of Bone and Joint Surgery - Series B

Volumn 92, Issue 1, 2010, Pages 159-163

  Aykut, S ^a   Ozturk A ^a   Ozkan Y ^a   Yanik, K ^a,b   Ilman, A A ^a,c   Ozdemir R M ^a  

^a BURSA YUKSEK IHTISAS TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b ULUDAG UNIVERSITY   (Turkey)

^c Dogal Yasami Koruma Merkezi   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CLINDAMYCIN; TEICOPLANIN; TITANIUM; ANTIINFECTIVE AGENT; BIOMATERIAL;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GROWTH; BACTERIUM CULTURE; CONTROLLED STUDY; DRUG EFFICACY; KIRSCHNER WIRE; NONHUMAN; PRIORITY JOURNAL; RABBIT; STAPHYLOCOCCUS AUREUS; TIBIA; WOUND; ANIMAL; BACTERIAL COUNT; CELL CULTURE; FEMALE; INFECTION; MATERIALS TESTING; MICROBIOLOGY; PROSTHESES AND ORTHOSES; RANDOMIZATION; STAPHYLOCOCCUS INFECTION;

ANIMALS; ANTI-BACTERIAL AGENTS; CELLS, CULTURED; CLINDAMYCIN; COATED MATERIALS, BIOCOMPATIBLE; COLONY COUNT, MICROBIAL; FEMALE; MATERIALS TESTING; PROSTHESES AND IMPLANTS; PROSTHESIS-RELATED INFECTIONS; RABBITS; RANDOM ALLOCATION; STAPHYLOCOCCAL INFECTIONS; TEICOPLANIN; TIBIA; TITANIUM;

EID: 75649131521     PISSN: 0301620X     EISSN: None     Source Type: Journal    
DOI: 10.1302/0301-620X.92B1.22134     Document Type: Article

References (57)

1. Periti P, Stringa G, Mini E. Comparative multicenter trial of teicoplanin versus cefazolin for antimicrobial prophylaxis in prosthetic joint implant surgery. Eur J Clin Microbiol Infect Dis 1999;18:113-19.
2. Mader JT, Landon GC, Calhoun J. Antimicrobial treatment of osteomyelitis. Clin Orthop 1993;295:87-95.
3. Price JS, Tencer AF, Arm DM, Bohach GA. Controlled release of antibiotics from coated orthopedic implants. J Biomed Mater Res 1996;30:281-6.
4. Bengtson S, Borgquist L, Lindgren L. Cost analysis of prophylaxis with antibiotics to prevent infected knee arthroplasty. BMJ 1989;299:719-20.
5. Sanderson PJ. Preventing infection in orthopaedic implants. J Antimicrob Chemother 1989;24:277-80.
6. Taylor GJ, Bannister GC, Calder S. Perioperative wound infection in elective orthopaedic surgery. J Hosp Infect 1990;16:241-7.
7. Southorn PA, Plevak DJ, Wright AJ, Wilson WR. Adverse effects of vancomycin administered in the perioperative period. Mayo Clin Proc 1986;61:721-4.
8. Suter F, Avai A, Fusco U, et al. Teicoplanin versus cefamandole in the prevention of infection in total hip replacement. Eur J Clin Microbiol Infect Dis 1994;13:703-6.
9. Wall R, Klenerman L, McCullough C, Fyfe I. A comparison of teicoplanin and cefuroxime as prophylaxis for orthopaedic implant surgery: a preliminary report. J Antimicrob Chemother 1988;21(Suppl):141-6.
10. Gristina AG, Costerton JW. Bacterial adherence to biomaterials and tissue: the significance of its role in clinical sepsis. J Bone Joint Surg [Am] 1985;67-A:264-73.
11. Gristina AG, Oga M, Webb LX, Hobgood CD. Adherent bacterial colonization in the pathogenesis of osteomyelitis. Science 1985;228:990-3.
12. Bucholz HW, Engelbrecht H. Depot effects of various antibiotics mixed with Palacos resins. Chirurg 1970;41:511-15.
13. Bertazzoni Minelli E, Caveiari C, Benini A. Release of antibiotics from polymethylmethacrylate cement. J Chemother 2002;14:492-500.
14. Henry SL, Ostermann PA, Seligson D. The prophylactic use of antibiotic beads in open fractures. J Trauma 1990;30:1231-8.
15. Klemm K. Gentamicin-PMMA beads in treating bone and soft tissue infections. Zentalbl Chir 1979;104:934-42 (in German).
16. Wenke JC, Owens BD, Svoboda SJ, Brooks DE. Effectiveness of commercially-available antibiotic-impregnated implants. J Bone Joint Surg [Br] 2006;88-B:1102-4.
17. Forster H, Marotta JS, Heseltine K, Milner R, Jani S. Bactericidal activity of antimicrobial coated polyurethane sleeves for externasl fixation pins. J Orthop Res 2004;22:671-7.
18. Kazimoglu C, Karapinar H, Sener M, et al. In vitro evaluation of gentamicin and teicoplanin release from cancellous human bone. Acta Orthop Traumatol Turc 2008;42:64-9 (in Turkish).
19. Stemberger A, Grimm H, Bader F, Rahn HD, Ascherl R. Local treatment of bone and soft tissue infections with the collagen-gentamicin sponge. Eur J Surg 1997;578:17-26.
20. Orhan Z, Cevher E, Mülazimoglu L, et al. The preparation of ciprofloxacin hydrochloric-loaded chitosan and pectin microspheres: their evaluation in an animal osteomyelitis model. J Bone Joint Surg [Br] 2006;88-B:270-5.
21. Ostermann OA, Henry SL, Seligson D. The role of local antibiotic therapy in the management of compound fractures. Clin Orthop 1993;295:102-11.
22. Evans RP, Nelson CL. Gentamicin-impregnated polymethylmethacrylate beads compared with systemic antibiotic therapy in the treatment of chronic osteomyelitis. Clin Orthop 1992;295:37-42.
23. Paley D, Herzenberg JE. Intramedullary infections treated with antibiotic cement rods: preliminary results in nine cases. J Orthop Trauma 2002;16:723-9.
24. Chiu FY, Lin CF, Chen CM, Lo WH, Chaung TY. Cefuroxime-impregnated cement at primary total knee arthroplasty in diabetes mellitus: a prospective, randomised study. J Bone Joint Surg [Br] 2001;83-B:691-5.
25. Liu HT, Chiu FY, Chen CM, Chen TH. The combination of systemic antibiotics and antibiotic impregnated cement in primary total knee arthroplasty in patients of rheumatoid arthritis: evaluation of 60 knees. J Chin Med Assoc 2003;66:533-6.
26. Lucke M, Schmidmaier G, Sadoni S, et al. Gentamicin coating of metallic implants reduces implant-related osteomyelitis in rats. Bone 2003;32:521-31.
27. Lucke M, Wildermann B, Sadoni S, et al. Systemic versus local application of gentamicin in prophylaxis of implant-related osteomyelitis in a rat model. Bone 2005;36:770-8.
28. Antoci V Jr, King SB, Jose B, et al. Vancomycin covalently bonded to titanium alloy prevents bacterial colonization. J Orthop Res 2007;25:858-66.
29. Antoci V Jr, Adams CS, Hickok NJ, Shapiro IM, Parvizi J. Antibiotics for local delivery systems cause skeletal cell toxicity in vitro. Clin Orthop 2007;462:200-6.
30. Darouiche RO, Mansouri MD, Zakarevicz D, AlSharif A, Landon GC. In vivo efficacy of antimicrobial-coated devices. J Bone Joint Surg [Am] 2007;89-A:792-7.
31. Montali A. Antibacterial coating systems. Injury 2006;37(Suppl 2):81-6.
32. Abouassaly R, Montague DK, Angermeier KW. Antibiotic-coated medical devices: with an emphasis on inflatable penile prosthesis. Asian J Androl 2004;6:249-57.
33. Zelken J, Wanich T, Gardner M, Griffith M, Bostrom M. PMMA is superior to hydroxyapatite for colony reduction in induced osteomyelitis. Clin Orthop 2007;462:190-4.
34. Darouiche RO. Device-assisted infections: a macroproblem that starts with microadherence. Clin Infect Dis 2001;33:1567-72.
35. Sherertz RJ, Carruth WA, Hampton AA, Byron MP, Solomon DD. Efficacy of antibiotic-coated catheters in preventing subcutaneous staphylococcus aureus infection in rabbits. J Infect Dis 1993;167:98-106.
36. Raad I, Darouiche R, Dupuis J, et al. Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream infections: a randomized, double-blind trial. Ann Intern Med 1997;127:267-74.
37. Chatzinikolaou I, Hanna H, Graviss L, et al. Clinical experience with minocycline and rifampin-impregnated central venous catheters in bone marrow transplantation recipients: efficacy and low risk of developing staphylococcal resistance. Infect Control Hosp Epidemiol 2003;24:961-3.
38. Hanna H, Benjamin R, Chatzinikolaou I, et al. Long-term silicone central venous catheters impregnated with minocycline and rifampin decreases rates of catheter-related bloodstream infection in cancer patients: a prospective randomized clinical trial. J Clin Oncol 2004;22:3163-71.
39. Darouiche RO, Berger DH, Khardori N, et al. Comparison of antimicrobial impregnation with tunneling of long-term central venous catheters: a randomized controlled trial. Ann Surg 2005;242:193-200.
40. Periti P, Mini E, Mosconi G. Antimicrobial prophylaxis in orthopedic surgery: the role of teicoplanin. J Antimicrob Chemother 1998;41:329-40.
41. Greenwood D. Microbiological properties of teicoplanin. J Antimicrob Chemother 1998;21(Suppl A):1-13.
42. Parenti F, Schito GC, Courvalin P. Teicoplanin chemistry and microbiology. J Chemother 2000;12(Suppl 5):5-14.
43. Shea KW, Cunha BA. Teicoplanin. Med Clin North Am 1995;79:833-44.
44. Drago L, De Vecchi E, Fassina MC, Gismondo MR. Serum and bone concentrations of teicoplanin and vancomycin: study in an animal model. Drugs Exp Clin Res 1998;24:185-90.
45. Campoli-Richards DM, Brogden RN, Faulds D. Teicoplanin: a review of its antibacterial activity, pharmacokinetics properties and therapeutic potential. Drugs 1990;40:449-86.
46. Naal FD, Salzmann GM, von Knoch F, et al. The effects of clindamycin on human osteoblasts in vitro. Arch Orthop Trauma Surg 2008;128:317-23.
47. Spizek J, Rezanka T. Lincomyvin, clindamycin and their applications. Appl Microbiol Biotechnol 2004;64:455-64.
48. Norden CW, Shinner E, Niederriter K. Clindamycin treatment of experimental chronic osteomyelitis due to Staphylococcus aureus. J Infect Dis 1986;153:956-9.
49. Summersgill JT, Schupp LG, Raff MJ. Comparative penetration of metranidazole, clindamycin, cloraphenicol, cefoxitin, ticarcillin and moxalactam into bone. Antimicrob Agents Chemother 1982;21:601-3.
50. Kalteis T, Beckmann J, Schröder HJ, et al. Treatment of implant-associated infectious with moxifloxacin: an animal study. Int J Antimicrob Agents 2006;27:444-8.
51. Kim H, Choi SH, Ryu JJ, et al. The biocompatibility of SLA-treated titanium implants. Biomed Mater 2008;3:25011.
52. Moojen DJ, Vogely HC, Fleer A, et al. Prophylaxis of infection and effects on osseointegration using a tobramycin-periapatite coating on titanium implants: an experimental study in the rabbit. J Orthop Res 2009;27:710-16.
53. Eaninwene G 2nd, Yao C, Webster TJ. Enhanced osteoblast adhesion to drug-coated anodized nanotubular titanium surfaces. Int J Nanomedicine 2008;3:257-64.
54. Rogers-Foy JM, Powers DL, Brosnan DA, et al. Hydroxyapatite composites designed for antibiotic drug delivery and bone reconstruction: a caprine model. J Invest Surg 1999;12:263-75.
55. Yamashita Y, Uchida A, Yamakawa T, et al. Treatment of chronic osteomyelitis using calcium hydroxyapatite ceramic implants impregnated with antibiotic. Int Orthop 1998;22:247-51.
56. Bourne RB. Prophylactic use of antibiotic bone cement: an emerging standard: in the affirmative. J Arthroplasty 2004;19(Suppl 1):69-72.
57. Ismael F, Bléton R, Saleh-Mghir A, et al. Teicoplanin-containing cement spacers for treatment of experimental Staphylococcus aureus joint prosthesis infection. Antimicrob Agents Chemother 2003;47:3365-7.